← Back to Search

Whole Body Vibration for Peripheral Neuropathy

N/A
Waitlist Available
Led By Kerri Winters-Stone, PhD
Research Sponsored by OHSU Knight Cancer Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up before and after every whole body vibration session, up to 2 times per day, 7 days per week, for 12 weeks
Awards & highlights

Study Summary

This trial looks at whether whole body vibration can help improve the health of people with chemotherapy-induced peripheral neuropathy.

Eligible Conditions
  • Chemotherapy-induced Peripheral Neuropathy
  • Blood Cancers
  • Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~before and after every whole body vibration session, up to 2 times per day, 7 days per week, for 12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and before and after every whole body vibration session, up to 2 times per day, 7 days per week, for 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Accrual
Adherence
Adverse events
+1 more
Secondary outcome measures
Body mass index
Pain
Exercise readiness
+11 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Whole body vibration (WBV)Experimental Treatment1 Intervention
Participants assigned to the WBV group will participate in twice daily 10-minute WBV training sessions, 7 days a week. Each WBV session will consist of a series of timed stands on the vibration platform (Marodyne LiV). During a timed stand, participants will perform slow controlled weight shifting exercises and gentle squats. The vibration frequency will be set at 30Hz and the amplitude set at 50-200 microns, for a total body acceleration of 0.4g+/-20%.
Group II: Usual Care (UC)Active Control1 Intervention
Participants randomly assigned to the UC group will serve as controls and will be tested at the same time points as the WBV group. The UC group will be asked not to change their physical activity or dietary habits across the intervention period and we will track any changes using a questionnaire.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Whole Body Vibration
2016
Completed Phase 4
~360

Find a Location

Who is running the clinical trial?

OHSU Knight Cancer InstituteLead Sponsor
231 Previous Clinical Trials
2,090,630 Total Patients Enrolled
Oregon Health and Science UniversityOTHER
979 Previous Clinical Trials
7,386,423 Total Patients Enrolled
1 Trials studying Peripheral Neuropathy
1 Patients Enrolled for Peripheral Neuropathy
Kerri Winters-Stone, PhDPrincipal InvestigatorOHSU Knight Cancer Institute
3 Previous Clinical Trials
419 Total Patients Enrolled
~7 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top